Roche Puts Hold on Tamiflu in United States - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Roche Puts Hold on Tamiflu in United States


ePT--the Electronic Newsletter of Pharmaceutical Technology

Roche Puts Hold on Tamiflu in United States

Roche (Basel, Switzerland, www.roche.com) has put a temporary halt on distribution of the influenza vaccine "Tamiflu" to the United Sates in an effort to deter companies from stockpiling the vaccine for employee use, according to an article in the Oct. 27 edition of The New York Times.

According to the report, the hoarding is a reaction to the recent avian flu pandemic, which has killed more than 60 people in Asia, but has not threatened the United States. Roche representatives stated that there are currently sufficient allotments of the vaccine in the United States and additional quantities will be released as the need arises. However, wholesalers were advised to limit the amount of drug distributed to pharmacies to “preserve their inventory until the beginning of flu season.”

Roche has also suspended shipments to Canada and limited supplies to Germany and Switzerland, according to The Times.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here